Cargando…
Potassium-competitive acid blockers - are they the next generation of proton pump inhibitors?
The modern lifestyle caters to an increase in the incidence of peptic ulcer disease, gastroesophageal reflux disease and several other acid-related conditions of the gut. The drugs to prevent these conditions work either through H2 receptor blockade or inhibition of the H(+), K(+) ATPase enzyme. Alt...
Autores principales: | Rawla, Prashanth, Sunkara, Tagore, Ofosu, Andrew, Gaduputi, Vinaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305499/ https://www.ncbi.nlm.nih.gov/pubmed/30595950 http://dx.doi.org/10.4292/wjgpt.v9.i7.63 |
Ejemplares similares
-
Fecal microbiota transplant – a new frontier in inflammatory bowel disease
por: Sunkara, Tagore, et al.
Publicado: (2018) -
Klippel-Trenaunay Syndrome, a Rare Cause of Hematochezia
por: Then, Eric Omar, et al.
Publicado: (2018) -
Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
por: Rawla, Prashanth, et al.
Publicado: (2019) -
Gastric mucosal prolapse: A case of proton‐pump inhibitor nonresponsive dyspepsia
por: Sunkara, Tagore, et al.
Publicado: (2018) -
Burkitt's Lymphoma of the Gastrohepatic Omentum: A Malignant Presentation of Pseudoachalasia
por: Then, Eric Omar, et al.
Publicado: (2019)